Article Per Year (5 Year)
p-Index From 2021 - 2026
0.23
P-Index
This Author published in this journals
All Journal IJHABS
Nidrah Nidrah
a:1:{s:5:"en_US";s:27:"Universitas Negeri Makassar";}
Computer Science & IT Decision Sciences, Operations Research & Management Economics, Econometrics & Finance Law, Crime, Criminology & Criminal Justice Library & Information Science

Published : 1 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 1 Documents
Search

 1 
Beyond the Pandemic: A Descriptive Analysis of Return Performance in Indonesia’s Healthcare Stocks Nidrah Nidrah; Andi Nurfiana Haz; Fitriani Rahim
International Humanity Advance, Business & Sciences Vol 3 No 4 (2026): April
Publisher : PT Maju Malaqbi Makkarana

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.59971/ijhabs.v3i4.1162

Abstract

This study describes the return performance of selected healthcare stocks listed on the Indonesia Stock Exchange during the post-pandemic period. Using a quantitative descriptive design, monthly stock returns were calculated from closing prices for January 2021 to December 2025 and analyzed using mean, minimum, maximum, standard deviation, and cumulative return. The sample consists of eight healthcare-related firms representing pharmaceuticals, herbal and consumer health products, hospitals, and diagnostic services: KLBF, SIDO, TSPC, MIKA, HEAL, SILO, PRDA, and SAME. The results show heterogeneous return characteristics across firms. SILO records the highest mean monthly return at 3.00%, followed by SAME at 1.91%, HEAL at 1.56%, and TSPC at 1.34%. In contrast, SIDO and KLBF show negative average returns, while MIKA is nearly neutral. Risk dispersion is also evident: SAME, PRDA, and SILO exhibit the highest standard deviations, whereas TSPC records the lowest volatility. These findings indicate that healthcare stocks retain defensive relevance after the pandemic but are not homogeneous in risk-return behavior. The study provides an empirical descriptive profile for investors and academics without making causal claims.
Co-Authors Andi Nurfiana Haz Fitriani Rahim